ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,867.08
-0.09%
US Tech 100
20,566.80
0.00%
Dow Jones
42,342.24
0.04%
Brent Oil
72.205
-0.25%
Bitcoin
96,042.13
-1.46%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Zomedica Corp (ZOM) Quote

Zomedica Corp

Zomedica Corp (ZOM)

ZoomInfo Technologies Inc
Zomedica Pharmaceuticals Corp
0.12
0.00
(0.00%)
Closed December 20 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.12
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.117 52 Week Range 0.2285
Market Cap
117.594M
Previous Close
0.12
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,222,883
Shares Outstanding
979,949,668
Dividend Yield
-
PE Ratio
-7.95
Earnings Per Share (EPS)
-0.04
Revenue
25.19M
Net Profit
-34.53M

About Zomedica Corp

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The comp... Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment. Show more

Sector
Testing Laboratories
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.zomedica.com
Headquarters
Ann Arbor, Michigan, USA
Founded
2016
Zomedica Corp is listed in the Testing Laboratories sector of the American Stock Exchange with ticker ZOM. The last closing price for Zomedica was $0.12. Over the last year, Zomedica shares have traded in a share price range of $ 0.117 to $ 0.2285.

Zomedica currently has 979,949,668 shares outstanding. The market capitalization of Zomedica is $117.59 million. Zomedica has a price to earnings ratio (PE ratio) of -7.95.

Ask ADVFN Intelligence (AI)

ZOM Latest News

More News

Form 8-K - Current report

11 hours ago
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

November 26 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 08 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0025-2.040816326530.12250.12390.11860286360.12033221CS
4-0.0095-7.335907335910.12950.13540.11849338410.12510926CS
12-0.0087-6.759906759910.12870.15480.11752228830.12864775CS
26-0.022-15.49295774650.1420.16770.11740813310.13352011CS
52-0.102-45.94594594590.2220.22850.11748067410.14422519CS
156-0.23-65.71428571430.350.50.11782993400.24139074CS
260-0.196-62.02531645570.3162.910.0628258529650.7035002CS

ZOM - Frequently Asked Questions (FAQ)

What is the current Zomedica share price?
The current share price of Zomedica is $ 0.12
How many Zomedica shares are in issue?
Zomedica has 979,949,668 shares in issue
What is the market cap of Zomedica?
The market capitalisation of Zomedica is USD 117.59M
What is the 1 year trading range for Zomedica share price?
Zomedica has traded in the range of $ 0.117 to $ 0.2285 during the past year
What is the PE ratio of Zomedica?
The price to earnings ratio of Zomedica is -7.95
What is the cash to sales ratio of Zomedica?
The cash to sales ratio of Zomedica is 10.89
What is the reporting currency for Zomedica?
Zomedica reports financial results in USD
What is the latest annual turnover for Zomedica?
The latest annual turnover of Zomedica is USD 25.19M
What is the latest annual profit for Zomedica?
The latest annual profit of Zomedica is USD -34.53M
What is the registered address of Zomedica?
The registered address for Zomedica is 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, MICHIGAN, 48108
What is the Zomedica website address?
The website address for Zomedica is www.zomedica.com
Which industry sector does Zomedica operate in?
Zomedica operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 28.6921
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 38.73
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2714
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.665
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.1291
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 28.6921
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 38.73
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2714
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.665
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.1291
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 28.6921
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 38.73
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2714
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 25.665
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.1291
(0.00%)
0

ZOM Discussion

View Posts
Spumoni Spumoni 11 hours ago
That's right Stock Patrol, I'd give it 12 - 18 months. GLTU!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 days ago
Someday
👍️0
Spumoni Spumoni 4 days ago
This thing is going to explode one day, be patient.
👍 1
CarlCarlMcB CarlCarlMcB 2 weeks ago
Harpoon $$$$$ whale on 2.00 to 4.00
👍️0
Bayguy Bayguy 1 month ago
I have a starter order in at .125
👍️0
glenngroove glenngroove 1 month ago
Here is my new jam:
👍️0
glenn1919 glenn1919 1 month ago
ZOM..............................https://stockcharts.com/h-sc/ui?s=ZOM&p=W&b=5&g=0&id=p86431144783
👍️0
KingOfSwing...Trading KingOfSwing...Trading 1 month ago
I'll be back in for another trip to the ATM at the next pullback 
👍️0
Spumoni Spumoni 1 month ago
Unless you're a flipper why would you sell now? Buy, it has a price target of .25 and a buy rating. GLTA
👍️0
IRON_CROSS IRON_CROSS 1 month ago
The slowest gap fill in history. I wonder why the powers that be just simply refuse to let the .07-.08 gaps fill (4 yrs ago now) so this ticker can go up? Ridiculous!

👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Buy buy buy $$$$$$
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Harpoon $$$$$$$$$
👍️0
dingodave dingodave 2 months ago
Some chatter on the Redditt board that Chewy is going to buy a piece of ZOM. Anyone hear anything about that?
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Merry Christmas $$$$$$
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Runs in a five year cycle $$$$$ smells like chewy $$$$$$ you buy what you need $$$$$
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Lol
👍️0
George28 George28 2 months ago
Touche 👍
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
It’s better said investing more than they can keep up $$$$$
👍️0
George28 George28 2 months ago
Problem is, their spending is out pacing their income.
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Zero debt $$$$$$$weeee
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Take the helm $$$$$$
👍️0
CarlCarlMcB CarlCarlMcB 2 months ago
Common Robert $$$$$$ weeeeee
👍️0
CarlCarlMcB CarlCarlMcB 3 months ago
2.00 to 4.00 mark it $$$$$$$$$
👍️0
CarlCarlMcB CarlCarlMcB 3 months ago
Bait the hook $$$$$ whale on $$$$$ weeeee$$$$$$ enjoy the ride $$$$$$
👍️0
MikeyInTheD MikeyInTheD 4 months ago
Quarter wasn’t that bad given everything happening over the past year. Business will stabilize and grow in the second half of the year. A second way to finance/try before you buy should help introduce the product to more clinics. The disposables income should continue growing and International success isn’t baked into the numbers yet.

Share price compliance is the wildcard. $83mm in cash with no debt. A buyback would make sense if they are projecting cash burn to remain at historical levels. I think they could even have positive cash flow in the next 12 months. Companies never buy their own stock when it’s cheap.
👍️0
GolfFishSurf GolfFishSurf 4 months ago
The only "takeoff" here was in the very beginning of 2021. Since the high of $2.91, it has been nothing but straight downhill. Unfortunately, this has nothing to bring it back up more than a few pennies. Do you see any real catalyst(s) for a substantial rise?
👍️0
MikeyInTheD MikeyInTheD 4 months ago
This has been too cheap for too long. Message board is silent. Perfect buying opportunity. Get in before this takes off.
👍️0
MikeyInTheD MikeyInTheD 5 months ago
Buy and hold. This is a set it and forget it stock for the long-term. Balance sheet improving and revenue looks promising. This could be a 5x gain any day now and $3.25 in the next 12 months.
👍️0
IRON_CROSS IRON_CROSS 6 months ago
There is still a gap @.0842 that occurred on 12 Nov 2021 that has yet to be filled...

>>> r/s 100% absolutely going to happen ... then maybe fill that gap ... then and only then MAYBE ZOM will have it's day. Until the inevitable happens ... DEAD Play ,, On Watch.

👍️0
cclover cclover 6 months ago
Please Remember that Voting for the Board Members and Employee Compensation Happens Tomorrow.
👍️0
Termite7 Termite7 7 months ago
LoL, pipeline? None found.....probably_'cuz_only_AMEX...........
👍️0
Harbor6460 Harbor6460 7 months ago
Penny stock has no vibe rite now. Buy Google
👍️0
AlbisA AlbisA 9 months ago
Why is so much selling? Lol
👍️0
AlbisA AlbisA 9 months ago
Vote for what?
👍️0
KingOfSwing...Trading KingOfSwing...Trading 9 months ago
They received my “no” vote
👍️0
AlbisA AlbisA 9 months ago
Why is nobody talking about $ZOM? I did my DD and can’t find one thing that is bad nor wrong about Zomedica.

1April is the earnings date for all the 2023 quarters + $2million in debt AND WITH OVER $100 million in cash reserves.

Load up my friends till you can (:
👍️0
Ruben3009 Ruben3009 10 months ago
This is the load up zone. R/S will inevitably fail. Larry Heaton stated stock buyback is out of a question, So, we are going back to 0.20+ to gain compliance. Load up people!
👍️0
cclover cclover 10 months ago
With the surplus cash on hand why not do a stock buyback. I'm afraid if this r/s happens that they will eventually issue more shares thus counteracting the reason for the split in the first place. Please consider the massive losses already absorbed by the long term holders and vote NO!
👍️0
glenngroove glenngroove 10 months ago
Down, down, down........where will she stop, nobody knows
👍️0
George28 George28 10 months ago
Do share your “guarantee” clairvoyance.
👍️0
Disquisition Disquisition 10 months ago
The R/S will be approved.

I “guarantee” it.
👍️0
George28 George28 11 months ago
I think that the consensus is a resounding NO. Most are down and a RS would decimate the price. The company is in a completely different place than they were a few years ago, I don’t want to lose anymore myself, and voted NO with my 172K.
👍️0
Ruben3009 Ruben3009 11 months ago
To All my ZOMFam please vote against the reverse stock split 1:80. We are down 48% since last January 26, 2023. If the R/S split happens, we are going to loose an additional 75% of our holdings. Vote NO to R/S split. I much rather wait until it reaches compliance with the Amex than loose what I have left.
👍️0
CarlCarlMcB CarlCarlMcB 11 months ago
Buy out is in emit $$$$$$$$$$$))
👍️0
CarlCarlMcB CarlCarlMcB 11 months ago
Robert take the helm $$$$$$$$$$$$
👍️0
EPS EPS 11 months ago
Yesterday's news was welcomed by me. It is the logical thing to do and timing is appropriate considering the place the company is in their development. I believe this will cause a gradual increase in the company market cap.
👍️0
bunda bunda 11 months ago
stock is running to the ground today
👍️0
Spumoni Spumoni 1 year ago
Can't believe this board is so quiet the past couple of days meanwhile ZOM is making a lot of noise! GLTA
👍️0
CarlCarlMcB CarlCarlMcB 1 year ago
Looking good $ they have a commercial $$
I see 2.00 to 3.00 again $$$$$ bring back Robert $$$$$ set the hook $$$$$$$
👍️0
Spumoni Spumoni 1 year ago
The ZOMbies awaken! Let's go, GLTA!
👍️0

Your Recent History

AMEX
ZOM
Zomedica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads